Kattih Obada, Velanovich Vic
Division of Gastrointestinal Surgery, University of South Florida Morsani College of Medicine, Five Tampa General Circle 740, Tampa, FL, 33606, USA.
J Gastrointest Surg. 2023 Mar;27(3):534-543. doi: 10.1007/s11605-022-05458-y. Epub 2022 Sep 20.
The management of symptomatic choledocholithiasis remains a controversial issue. At present, the three most common management options for choledocholithiasis include a preoperative endoscopic retrograde cholangiopancreatography with sphincterotomy and stone extraction followed by laparoscopic cholecystectomy, then by either an intraoperative endoscopic retrograde cholangiopancreatography with sphincterotomy or a laparoscopic common bile duct exploration. The purpose of this study was to assess the consequences of the decision to pursue each of these three methods.
We conducted a review of the existing data comparing these three management options. The literature from 2009 to 2021 pertaining to these three methods was reviewed for data on duct clearance, morbidity, mortality, recurrence rate, length of stay, and operative time. Next, we constructed decision trees for each method using a utility score analysis, and these utility scores were used to create a sensitivity analysis based on stone clearance rate.
Laparoscopic cholecystectomy with intraoperative endoscopic retrograde cholangiopancreatography had a utility score of 0.9910, a stone clearance rate of 95.5%, a morbidity of 6.3%, and a mortality of 0.2%. Preoperative endoscopic retrograde cholangiopancreatography with laparoscopic cholecystectomy had a utility score of 0.9629, a stone clearance rate of 85.5%, a morbidity of 13.3%, and a mortality of 0.8%. Laparoscopic cholecystectomy with common bile duct exploration had a utility score of 0.9882, a stone clearance rate of 88.3%, a morbidity of 12.9%, and a mortality of 0.3%.
We have shown that a laparoscopic cholecystectomy with an intraoperative endoscopic retrograde cholangiopancreatography is associated with the best overall outcomes.
有症状的胆总管结石的治疗仍是一个有争议的问题。目前,胆总管结石最常见的三种治疗选择包括术前内镜逆行胰胆管造影术加括约肌切开取石术,随后行腹腔镜胆囊切除术,然后是术中内镜逆行胰胆管造影术加括约肌切开术或腹腔镜胆总管探查术。本研究的目的是评估采用这三种方法中每一种的决策后果。
我们对比较这三种治疗选择的现有数据进行了综述。回顾了2009年至2021年有关这三种方法的文献,以获取关于胆管清除率、发病率、死亡率、复发率、住院时间和手术时间的数据。接下来,我们使用效用评分分析为每种方法构建决策树,这些效用评分用于基于结石清除率创建敏感性分析。
腹腔镜胆囊切除术联合术中内镜逆行胰胆管造影术的效用评分为0.9910,结石清除率为95.5%,发病率为6.3%,死亡率为0.2%。术前内镜逆行胰胆管造影术联合腹腔镜胆囊切除术的效用评分为0.9629,结石清除率为85.5%,发病率为13.3%,死亡率为0.8%。腹腔镜胆囊切除术联合胆总管探查术的效用评分为0.9882,结石清除率为88.3%,发病率为12.9%,死亡率为0.3%。
我们已经表明,腹腔镜胆囊切除术联合术中内镜逆行胰胆管造影术具有最佳的总体结果。